• Will Icotyde’s Launch and Rusfertide’s Priority Review Change Protagonist Therapeutics’ (PTGX) Narrative simplywall.st Fri, 10 Jul 2026 03:59:07 GMT
• Protagonist Therapeutics (PTGX) Stock Still Looks Stretched After FDA Priority Review Yahoo Finance Thu, 09 Jul 2026 16:10:17 GMT
• Protagonist Therapeutics (PTGX) After Icotyde Launch And Rusfertide Review Looks Undervalued Yahoo Finance Thu, 09 Jul 2026 14:14:40 GMT
• Protagonist Therapeutics (PTGX) Could Be 66% Below Fair Value As Pipeline Progress Lifts Interest simplywall.st Wed, 08 Jul 2026 23:58:43 GMT
• Protagonist Therapeutics (PTGX) Is Up 12.5% After Rusfertide Priority Review Focus - Has The Bull Case Changed? Yahoo Finance Wed, 08 Jul 2026 16:18:23 GMT
• Protagonist Therapeutics (PTGX) Surges 7.1%: Is This an Indication of Further Gains? Yahoo Finance Wed, 08 Jul 2026 14:30:00 GMT
• strength seen in agios pharmaceuticals (agio): can its 17.7% jump turn into more strength? Yahoo Finance Singapore Wed, 08 Jul 2026 14:29:00 GMT
• Truist Financial Maintains Protagonist Therapeutics(PTGX.US) With Buy Rating, Announces Target Price $145 富途牛牛 Wed, 08 Jul 2026 00:13:13 GMT
• Protagonist Therapeutics updates its clinical pipeline. PTGX focuses on peptide-based therapies AD HOC NEWS Tue, 07 Jul 2026 17:28:48 GMT
• Protagonist Therapeutics Jumps 5.2% Amid Sector-Wide Rally AlphaStreet Tue, 07 Jul 2026 16:55:14 GMT
• PTGX Stock Surges 64% in Six Months: What Is Driving the Rally? TradingView Tue, 07 Jul 2026 15:15:00 GMT
• PTGX Maintained by Truist Securities -- Price Target Raised to $145.00 GuruFocus Tue, 07 Jul 2026 12:53:34 GMT
• Truist raises Protagonist Therapeutics stock price target on Icotyde outlook By Investing.com Investing.com Nigeria Tue, 07 Jul 2026 11:21:48 GMT
• Price to sales forward of Protagonist Therapeutics, Inc. – NASDAQ:PTGX TradingView Tue, 07 Jul 2026 11:00:31 GMT
• Truist Raises Price Target on Protagonist Therapeutics to $145 From $121, Keeps Buy Rating Moomoo Tue, 07 Jul 2026 10:28:56 GMT
• Protagonist Therapeutics Inc stock hits all-time high at 131.99 USD Investing.com Mon, 06 Jul 2026 14:15:44 GMT
• protagonist therapeutics updates its pipeline. ptgx focuses on peptide drug development AD HOC NEWS Fri, 03 Jul 2026 12:05:49 GMT
• Why Wall Street’s Wrong for Loving Protagonist Therapeutics Stock Yahoo Finance Thu, 02 Jul 2026 14:15:02 GMT
• The Bull Case For Protagonist Therapeutics (PTGX) Could Change Following Rusfertide Review Optimism And New Hires – Learn Why simplywall.st Thu, 02 Jul 2026 04:45:55 GMT
• Protagonist Therapeutics Reports Granting of Inducement Awards ACCESS Newswire Wed, 01 Jul 2026 20:11:55 GMT
• Protagonist Therapeutics awards new hires stock options and RSUs Stock Titan Wed, 01 Jul 2026 20:05:00 GMT
• Protagonist Therapeutics stock rating reiterated at Buy by TD Cowen Investing.com Wed, 01 Jul 2026 07:00:00 GMT
• Is Protagonist Therapeutics (PTGX) A Bargain As Its Pipeline Momentum Lifts The Stock? simplywall.st Tue, 30 Jun 2026 04:37:04 GMT
• why (ptgx) price action is critical for tactical trading Stock Traders Daily Sun, 28 Jun 2026 11:50:02 GMT
• wall street says johnson and johnson’s fda-approved psoriasis drug should create 'significant value' for protagonist therapeutics MSN Sat, 27 Jun 2026 21:44:38 GMT
• fda decision: rusfertide by protagonist therapeutics (in 2026) Coinbase Sat, 27 Jun 2026 08:09:37 GMT
• wall street says johnson and johnson’s fda-approved psoriasis drug should create 'significant value’ for protagonist therapeutics Stocktwits Fri, 26 Jun 2026 16:53:08 GMT
• protagonist therapeutics inc (ptgx) financial health: profitability & balance sheet analysis TradingKey Fri, 26 Jun 2026 07:00:00 GMT
• Form 4 Protagonist Therapeutics Inc For: 25 June By Investing.com Investing.com Nigeria Fri, 26 Jun 2026 03:51:10 GMT
• Protagonist Therapeutics, Inc. Actuals & Estimates (NASDAQ:PTGX) TradingView Thu, 25 Jun 2026 23:40:59 GMT
• Director at Protagonist (NASDAQ: PTGX) trades 9,000 shares under 10b5-1 plan Stock Titan Thu, 25 Jun 2026 20:10:53 GMT
• Protagonist Therapeutics stock hits all-time high at 124.97 USD By Investing.com Investing.com Nigeria Thu, 25 Jun 2026 16:37:22 GMT
• Protagonist Therapeutics director Waddill sells $1.06m in stock Investing.com Thu, 25 Jun 2026 07:00:00 GMT
• form 4 protagonist therapeutics inc for: 25 june by investing.com Investing.com UK Thu, 25 Jun 2026 07:00:00 GMT
• protagonist therapeutics inc (ptgx) valuation: pe, pb & fair value analysis TradingKey Thu, 25 Jun 2026 07:00:00 GMT
• protagonist therapeutics, inc. stock 12‑month price target raised to $119.15, implies 2% downside TradingView Thu, 25 Jun 2026 04:20:00 GMT
• why is silence therapeutics stock soaring wednesday? - silence therapeutics (nasdaq:sln) Benzinga Wed, 24 Jun 2026 18:22:30 GMT
• the bull case for protagonist therapeutics (ptgx) could change following surging institutional buying interest Sahm Wed, 24 Jun 2026 07:22:12 GMT
• Protagonist Therapeutics, Inc. Stock 12‑Month Price Target Raised to $119.15, Implies 2% Downside TradingView Wed, 24 Jun 2026 07:00:00 GMT
• protagonist therapeutics inc (ptgx) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• protagonist therapeutics inc (ptgx) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• form 144 protagonist therapeutics for: 23 june by investing.com Investing.com India Wed, 24 Jun 2026 01:25:02 GMT
• form 144 protagonist therapeutics for: 23 june by investing.com Investing.com Nigeria Tue, 23 Jun 2026 21:03:01 GMT
• the bull case for protagonist therapeutics (ptgx) could change following surging institutional buying interest simplywall.st Tue, 23 Jun 2026 11:37:17 GMT
• PTGX (NASDAQ) Form 144: Director-linked 9,000-share sales and option exercise Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• protagonist therapeutics inc (ptgx) earnings forecast: future eps & revenue growth estimates TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• protagonist therapeutics inc (ptgx) financial health: profitability & balance sheet analysis TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• protagonist therapeutics inc (ptgx) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• Truist Financial Maintains Protagonist Therapeutics(PTGX.US) With Buy Rating Moomoo Mon, 22 Jun 2026 11:31:00 GMT
• wall street says johnson and johnson’s fda-approved psoriasis drug should create 'significant value’ for protagonist therapeutics Stocktwits Mon, 22 Jun 2026 09:10:20 GMT
• protagonist therapeutics (ptgx) edges higher, testing key resistance zone near $118.5 - covered call trade Město Břeclav Sat, 20 Jun 2026 19:33:11 GMT
• Goldman Sachs Maintains Protagonist Therapeutics(PTGX.US) With Hold Rating, Maintains Target Price $110 富途牛牛 Fri, 19 Jun 2026 22:27:21 GMT
• wall street says johnson and johnson’s fda-approved psoriasis drug should create 'significant value' for protagonist therapeutics MSN Fri, 19 Jun 2026 07:43:10 GMT
• protagonist therapeutics adopts 2026 equity incentive plan following shareholder approval Minichart Fri, 19 Jun 2026 03:48:00 GMT
• protagonist therapeutics stock hits all-time high at 113.75 usd by investing.com Investing.com South Africa Fri, 19 Jun 2026 02:19:11 GMT
• protagonist therapeutics inc (ptgx) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 11:37:17 GMT
• protagonist therapeutics inc (ptgx) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 09:27:26 GMT
• protagonist therapeutics inc (ptgx) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 07:24:48 GMT
• Protagonist Therapeutics (PTGX) OKs 2026 equity plan and re-elects directors at annual meeting Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• protagonist therapeutics stock hits all-time high at 113.75 usd by investing.com Investing.com Nigeria Thu, 18 Jun 2026 07:00:00 GMT
• protagonist therapeutics inc (ptgx) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 04:39:40 GMT
• protagonist therapeutics inc (ptgx) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 03:02:50 GMT
• protagonist therapeutics inc (ptgx) institutional confidence TradingKey Wed, 17 Jun 2026 21:22:29 GMT
• ptgx: all proposals, including director elections and equity plan, were approved at the agm TradingView Wed, 17 Jun 2026 17:24:59 GMT
• protagonist therapeutics inc (ptgx) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 07:00:00 GMT
• protagonist therapeutics reports granting of inducement awards ACCESS Newswire Tue, 16 Jun 2026 20:02:36 GMT
• new hires at protagonist receive stock options at $112.46 Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
• protagonist therapeutics inc (ptgx) earnings forecast: future eps & revenue growth estimates TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• protagonist therapeutics inc (ptgx) institutional confidence TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• top damora therapeutics, inc. common stock (dmra) competitors 2026 MarketBeat Mon, 15 Jun 2026 21:45:06 GMT
• wall street says johnson and johnson’s fda-approved psoriasis drug should create 'significant value’ for protagonist therapeutics Stocktwits Mon, 15 Jun 2026 09:21:17 GMT
• nextbio capital management lp takes position in protagonist therapeutics, inc. $ptgx MarketBeat Sun, 14 Jun 2026 11:23:48 GMT
• protagonist therapeutics (ptgx) stock valuation after strong recent returns and premium p/b multiple simplywall.st Sun, 14 Jun 2026 07:00:00 GMT
• top damora therapeutics, inc. common stock (dmra) competitors 2026 MarketBeat Sat, 13 Jun 2026 20:30:38 GMT
• keystone investors pte ltd. buys shares of 26,390 protagonist therapeutics, inc. $ptgx MarketBeat Sat, 13 Jun 2026 11:10:44 GMT
• Protagonist Therapeutics: A Royalty-Driven Biotech With Two Shots On Goal (NASDAQ:PTGX) Seeking Alpha Sat, 13 Jun 2026 07:00:00 GMT
• Protagonist Therapeutics (NASDAQ:PTGX) Shows Technical Strength and High Growth Momentum ChartMill Sat, 13 Jun 2026 07:00:00 GMT
• top damora therapeutics, inc. common stock (dmra) competitors 2026 MarketBeat Fri, 12 Jun 2026 04:03:13 GMT
• protagonist therapeutics director waddill sells $969,120 in shares by investing.com Investing.com India Fri, 12 Jun 2026 00:17:25 GMT
• 571,825 shares in protagonist therapeutics, inc. $ptgx bought by nationale nederlanden powszechne towarzystwo emerytalne s.a. MarketBeat Thu, 11 Jun 2026 10:58:36 GMT
• Protagonist Therapeutics (NASDAQ: PTGX) director exercises 9,000 options, sells 9,000 shares under 10b5-1 plan Stock Titan Thu, 11 Jun 2026 07:00:00 GMT
• protagonist therapeutics director waddill sells $969,120 in shares Investing.com Thu, 11 Jun 2026 07:00:00 GMT
• protagonist therapeutics stock hits all-time high at 107.86 usd by investing.com Investing.com Nigeria Thu, 11 Jun 2026 05:42:17 GMT
• ptgx: icotyde's strong launch and a robust pipeline drive growth, with rusfertide approval expected soon TradingView Wed, 10 Jun 2026 15:19:54 GMT
• protagonist therapeutics inc at goldman sachs healthcare conference transcript GuruFocus Wed, 10 Jun 2026 13:20:00 GMT
• clearbridge investments llc buys shares of 489,842 protagonist therapeutics, inc. $ptgx MarketBeat Wed, 10 Jun 2026 07:58:21 GMT
• PTGX (NASDAQ) insider 10b5-1 sale of 9,000 shares; option exercise noted Stock Titan Wed, 10 Jun 2026 07:00:00 GMT
• protagonist therapeutics stock hits all-time high at 107.86 usd Investing.com Wed, 10 Jun 2026 07:00:00 GMT
• transcript : protagonist therapeutics, inc. presents at goldman sachs 47th annual global healthcare conference 2026, jun-10-2026 0... marketscreener.com Wed, 10 Jun 2026 07:00:00 GMT
• protagonist therapeutics director waddill sells $969,120 in shares by investing.com Investing.com Nigeria Wed, 10 Jun 2026 07:00:00 GMT
• protagonist therapeutics jumps 6.3% amid sector-wide rally AlphaStreet Wed, 10 Jun 2026 00:34:52 GMT
• protagonist therapeutics jumps 6.3% amid sector-wide rally AlphaStreet Tue, 09 Jun 2026 20:35:10 GMT
• bnp paribas financial markets has $8.54 million stock holdings in protagonist therapeutics, inc. $ptgx MarketBeat Tue, 09 Jun 2026 07:20:13 GMT
• protagonist therapeutics to participate in multiple investment bank conferences in september 2025 Salinas Californian Tue, 09 Jun 2026 06:08:18 GMT
• protagonist therapeutics stock rallies nearly 7% in a week: here's why MSN Sun, 07 Jun 2026 07:49:28 GMT
• assessing protagonist therapeutics (ptgx) valuation after positive rusfertide data and icotyde approval news Sahm Sat, 06 Jun 2026 18:29:39 GMT
• avoiding lag: real-time signals in (ptgx) movement Stock Traders Daily Sat, 06 Jun 2026 09:08:01 GMT
• geode capital management llc boosts stock holdings in protagonist therapeutics, inc. $ptgx MarketBeat Fri, 05 Jun 2026 07:51:44 GMT
• assessing protagonist therapeutics (ptgx) valuation after positive rusfertide data and icotyde approval news Sahm Fri, 05 Jun 2026 07:00:00 GMT
• citizens raises protagonist therapeutics stock price target on platform validation Investing.com Fri, 05 Jun 2026 07:00:00 GMT
• protagonist therapeutics jumps 6.1% amid sector-wide rally AlphaStreet Thu, 04 Jun 2026 07:00:00 GMT
• could new rusfertide data presentations subtly reframe protagonist therapeutics' (ptgx) core investment narrative? simplywall.st Thu, 04 Jun 2026 01:22:21 GMT
• ptgx: robust royalties, pipeline progress, and share buyback plans drive strong growth outlook TradingView Wed, 03 Jun 2026 15:19:42 GMT
• PTGX: Major partnerships, strong pipeline, and financial strength drive growth and shareholder returns TradingView Wed, 03 Jun 2026 07:00:00 GMT
• protagonist therapeutics director waddill sells $896,760 in common stock by investing.com Investing.com South Africa Tue, 02 Jun 2026 00:30:44 GMT
• Rusfertide results in polycythemia vera at European hematology congress Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• Protagonist Therapeutics to Present Phase 3 VERIFY and Long-Term Rusfertide Data at the 2026 European Hematology Association Congr... ACCESS Newswire Mon, 01 Jun 2026 07:00:00 GMT
• Director at Protagonist Therapeutics (PTGX) sells shares after exercising options Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• Protagonist Therapeutics director Waddill sells $896,760 in common stock Investing.com Mon, 01 Jun 2026 07:00:00 GMT
• jefferies financial group inc. sells 816,503 shares of protagonist therapeutics, inc. $ptgx MarketBeat Sun, 31 May 2026 07:00:00 GMT
• protagonist therapeutics (ptgx) soars 4.7%: is further upside left in the stock? MSN Sun, 31 May 2026 03:49:18 GMT
• why protagonist therapeutics stock skyrocketed by almost 30% today MSN Sat, 30 May 2026 22:56:14 GMT
• protagonist therapeutics, inc. (nasdaq:ptgx) receives consensus recommendation of "moderate buy" from analysts MarketBeat Sat, 30 May 2026 06:43:45 GMT
• protagonist therapeutics stock (us74374t1097): shares ease after recent run-up as investors eye valu AD HOC NEWS Fri, 29 May 2026 15:51:24 GMT
• fisher asset management llc makes new investment in protagonist therapeutics, inc. $ptgx MarketBeat Fri, 29 May 2026 07:58:42 GMT
• protagonist therapeutics stock rallies nearly 7% in a week: here's why MSN Fri, 29 May 2026 02:49:09 GMT
• protagonist therapeutics to present at two investment bank conferences in june 2026 geneonline.com Fri, 29 May 2026 00:32:07 GMT
• protagonist therapeutics (ptgx) stock forecast & analyst ratings Moomoo Thu, 28 May 2026 15:26:00 GMT
• protagonist therapeutics to participate in two investment bank conferences in june 2026 ACCESS Newswire Thu, 28 May 2026 11:08:29 GMT
• Protagonist CEO schedules two June healthcare conference talks Stock Titan Thu, 28 May 2026 07:00:00 GMT
• assessing protagonist therapeutics (ptgx) valuation after a year of strong share price gains simplywall.st Tue, 26 May 2026 22:26:10 GMT
• discipline and rules-based execution in ptgx response Stock Traders Daily Tue, 26 May 2026 08:00:02 GMT
• ptgx stock price, quote & chart | protagonist therapeutics inc (nasdaq:ptgx) ChartMill Tue, 26 May 2026 07:00:00 GMT
• protagonist therapeutics (nasdaq:ptgx) upgraded to "strong-buy" at wolfe research MarketBeat Fri, 22 May 2026 07:00:00 GMT
• wolfe research initiates protagonist therapeutics stock with outperform rating Investing.com Thu, 21 May 2026 07:00:00 GMT
• eagle health investments lp takes $5.01 million position in protagonist therapeutics, inc. $ptgx MarketBeat Thu, 21 May 2026 07:00:00 GMT
• ptgx stock price, quote & chart | protagonist therapeutics inc (nasdaq:ptgx) ChartMill Thu, 21 May 2026 07:00:00 GMT
• protagonist therapeutics stock rallies nearly 7% in a week: here's why MSN Wed, 20 May 2026 18:37:27 GMT
• protagonist therapeutics (ptgx) soars 4.7%: is further upside left in the stock? MSN Wed, 20 May 2026 06:20:35 GMT
• j.p. morgan maintains protagonist therapeutics(ptgx.us) with buy rating, raises target price to $113 富途牛牛 Tue, 19 May 2026 10:52:05 GMT
• protagonist therapeutics stock (us74374t1097): fda nod for rusfertide reshapes biotech story AD HOC NEWS Tue, 19 May 2026 02:16:14 GMT
• protagonist therapeutics stock rallies nearly 7% in a week: here's why MSN Mon, 18 May 2026 02:00:58 GMT
• protagonist therapeutics (ptgx) soars 4.7%: is further upside left in the stock? MSN Sun, 17 May 2026 13:12:54 GMT
Protagonist Therapeutics, Inc(NASDAQ:PTGX) 
Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. It is developing PTG-300, an injectable hepcidin mimetic that is in Phase II clinical trial for the treatment of patients with polycythem...
Website: http://www.protagonist-inc.com
Founded: 2006
Full Time Employees: 76
Sector: Healthcare
Industry: Biotechnology